Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
68.40    0.40 (0.59%)
Bid:
68.20
Ask:
68.40
Spread: 0.20 (0.293%)
Market Cap: £604.26m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Director Declaration

25 Nov 2020 07:00

RNS Number : 3921G
IP Group PLC
25 November 2020
 

FOR RELEASE ON

25 November 2020

 

Director Declaration

IP Group plc (LSE: IPO) ("the Group"), the developer of intellectual property-based businesses, confirms that Elaine Sullivan, a non-executive director of the Group, has been appointed as a director of Open Orphan plc and Active Biotech AB. This disclosure is made in accordance with LR 9.6.14R of the Listing Rules.

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Angela Leach, Company SecretaryLiz Vaughan-Adams, Communications

+44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7979 853802

 

Notes for editors

 

About IP Group

 

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNKKQBDCBDDFDB
Date   Source Headline
8th Nov 20247:00 amRNSTransaction in Own Shares
7th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20246:23 pmRNSTransaction in Own Shares
4th Nov 20245:08 pmRNSTransaction in Own Shares
4th Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 20247:01 amRNSTotal Voting Rights
1st Nov 20247:00 amRNSTransaction in Own Shares
31st Oct 20247:00 amRNSTransaction in Own Shares
30th Oct 20247:00 amRNSTransaction in Own Shares
29th Oct 20247:00 amRNSTransaction in Own Shares
25th Oct 20245:15 pmRNSTransaction in Own Shares
25th Oct 20247:00 amRNSTransaction in Own Shares
24th Oct 20247:00 amRNSTransaction in Own Shares
23rd Oct 20247:00 amRNSTransaction in Own Shares
22nd Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 20247:00 amRNSTransaction in Own Shares
18th Oct 20247:00 amRNSTransaction in Own Shares
16th Oct 20245:59 pmRNSTransaction in Own Shares
15th Oct 20246:24 pmRNSTransaction in Own Shares
15th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 20245:44 pmRNSTransaction in Own Shares
11th Oct 20247:00 amRNSTransaction in Own Shares
9th Oct 20245:34 pmRNSTransaction in Own Shares
8th Oct 20245:31 pmRNSTransaction in Own Shares
8th Oct 20247:00 amRNSTransaction in Own Shares
7th Oct 20247:00 amRNSShare buyback programme extension
1st Oct 20247:00 amRNSTotal Voting Rights
26th Sep 20242:12 pmRNSVisa to acquire portfolio company Featurespace
17th Sep 20247:01 amRNSHalf-yearly results
17th Sep 20247:00 amRNSTransaction in Own Shares
13th Sep 20245:30 pmRNSTransaction in Own Shares
13th Sep 20247:00 amRNSTransaction in Own Shares
11th Sep 20244:55 pmRNSTransaction in Own Shares
11th Sep 20247:00 amRNSTransaction in Own Shares
10th Sep 20247:00 amRNSTransaction in Own Shares
6th Sep 20244:56 pmRNSTransaction in Own Shares
6th Sep 20243:48 pmRNSHolding(s) in Company
6th Sep 20247:00 amRNSTransaction in Own Shares
5th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSTransaction in Own Shares
3rd Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 20247:00 amRNSTotal Voting Rights
30th Aug 20246:16 pmRNSTransaction in Own Shares
30th Aug 20247:00 amRNSTransaction in Own Shares
29th Aug 20247:00 amRNSTransaction in Own Shares
29th Aug 20247:00 amRNSTransaction in Own Shares
28th Aug 20247:00 amRNSTransaction in Own Shares
23rd Aug 20245:18 pmRNSTransaction in Own Shares
22nd Aug 20245:10 pmRNSTransaction in Own Shares
21st Aug 20246:25 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.